Potentially prognostic factors of overall survival in advanced biliary tract cancer in the randomised phase III TOPAZ-1 study

被引：1

作者：

He, A. R. ^{[1
]}

Bouattour, M. ^{[2
]}

Gupta, V. G. ^{[3
]}

Evesque, L. ^{[4
]}

Zhen, D. B. ^{[5
]}

Park, J. O. ^{[6
]}

Sookprasert, A. ^{[7
]}

Salvatierra, A. ^{[8
]}

Vaccaro, G. M. ^{[9
]}

Oh, S. C. ^{[10
]}

Ostoich, S. A. ^{[11
]}

Satoh, T. ^{[12
]}

Zotkiewicz, M. ^{[13
]}

Rokutanda, N. ^{[14
]}

Kim, H. ^{[15
]}

Oh, D-Y. ^{[16
,17
]}

机构：

[1] Georgetown Univ, Div Hematol & Oncol, Lombardi Comprehens Canc Ctr, Washington, DC USA

[2] Hop Beaujon, AP HP, 2Med Oncol, Paris, France

[3] Artemis Hosp, Dept Med Oncol, Delhi, India

[4] Med Oncol Dept, Ctr Antoine Lacassagne, Nice, France

[5] Univ Washington, Div Med Oncol, Dept Internal Med, Fred Hutchinson Canc Ctr, Seattle, WA USA

[6] Sung kyunkwan Univ, Div Hematol Oncol, Dept Med, Samsung Med Ctr,Sch Med, Seoul, South Korea

[7] Khon Kaen Univ, Dept Med, Med Oncol Unit, Fac Med, Khon Kaen, Thailand

[8] Fdn Ars Med, San Salvador De Jujuy, Jujuy, Argentina

[9] Providence Canc Inst, Clin Oncol, Portland, OR USA

[10] Korea Univ, Dept Internal Med, Coll Med, Div Hematol & Oncol, Seoul, South Korea

[11] Hosp Prov Centenario, Dept Oncol, Rosario, Argentina

[12] Osaka Univ, Dept Frontier Sci Canc & Chemotherapy, Grad Sch Med, Osaka, Japan

[13] AstraZeneca, Late Oncol Stat, Oncol Biometr, Warsaw, Poland

[14] AstraZeneca, Oncol R&D, Late Stage Dev, Gaithersburg, MD USA

[15] AstraZeneca, Statist, Osaka, Japan

[16] Seoul Natl Univ, Dept Internal Med, Div Med Oncol, Coll Med,Seoul Natl Univ Hosp, Seoul, South Korea

[17] Seoul Natl Univ, Canc Res Inst, Coll Med, Seoul, South Korea

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.1395

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

102P

引用

页码：S220 / S220

页数：1

共 50 条

[1] Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1) : updated overall survival from a randomised phase 3 study
Oh, Do-Youn
He, Aiwu Ruth
Bouattour, Mohamed
Okusaka, Takuji
Qin, Shukui
Chen, Li-Tzong
Kitano, Masayuki
Lee, Choong-kun
Kim, Jin Won
Chen, Ming -Huang
Suksombooncharoen, Thatthan
Ikeda, Masafumi
Lee, Myung Ah
Chen, Jen-Shi
Potemski, Piotr
Burris, Howard A.
Ostwal, Vikas
Tanasanvimon, Suebpong
Morizane, Chigusa
Zaucha, Renata E.
Mcnamara, Mairead G.
Avallone, Antonio
Cundom, Juan E.
Breder, Valeriy
Tan, Benjamin
Shimizu, Satoshi
Tougeron, David
Evesque, Ludovic
Petrova, Mila
Zhen, David B.
Gillmore, Roopinder
Gupta, Vineet Govinda
Dayyani, Farshid
Park, Joon Oh
Buchschacher Jr, Gary L.
Rey, Felipe
Kim, Hyosung
Wang, Julie
Morgan, Claire
Rokutanda, Nana
Zotkiewicz, Magdalena
Vogel, Arndt
Valle, Juan W.
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (08): : 694 - 704
[2] Durvalumab Plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer (TOPAZ-1)
Choe, Jung Wan
KOREAN JOURNAL OF GASTROENTEROLOGY, 2023, 82 (02): : 105 - 106
[3] Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancer
Oh, Do-Youn
He, Aiwu Ruth
Qin, Shukui
Chen, Li-Tzong
Okusaka, Takuji
Vogel, Arndt
Kim, Jin Won
Suksombooncharoen, Thatthan
Lee, Myung Ah
Kitano, Masayuki
Burris, Howard
Bouattour, Mohamed
Tanasanvimon, Suebpong
McNamara, Mairead G.
Zaucha, Renata
Avallone, Antonio
Tan, Benjamin
Cundom, Juan
Lee, Choong-kun
Takahashi, Hidenori
Ikeda, Masafumi
Chen, Jen-Shi
Wang, Julie
Makowsky, Mallory
Rokutanda, Nana
Zotkiewicz, Magdalena
Kurland, John F.
Cohen, Gordon
Valle, Juan W.
FUTURE ONCOLOGY, 2023, 19 (34) : 2277 - 2289
[4] Outcomes by disease status in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase III TOPAZ-1 study
Okusaka, T.
Kitano, M.
Chen, M-H.
Chen, J-S.
Ostwal, V. S.
McNamara, M. G.
Breder, V.
Petrova, M.
Buchschacher, G.
Rokutanda, N.
Xiong, J.
Cohen, G.
Oh, D-Y.
ANNALS OF ONCOLOGY, 2022, 33 : S1471 - S1471
[5] TOPAZ-1: a new standard of care for advanced biliary tract cancers?
Ebia, Matthew, I
Sankar, Kamya
Osipov, Arsen
Hendifar, Andrew E.
Gong, Jun
IMMUNOTHERAPY, 2023, 15 (07) : 473 - 476
[6] Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin ( plus GC) in patients (pts) with advanced biliary tract cancer (BTC)
Oh, D. Y.
He, A. R.
Qin, S.
Chen, L. T.
Okusaka, T.
Vogel, A.
Kim, J. W.
Suksombooncharoen, T.
Lee, M. A.
Kitano, M.
Burris, H. A.
Bouattour, M.
Tanasanvimon, S.
Zaucha, R. E.
Avallone, A.
Cundom, J. E.
Rokutanda, N.
Watras, M.
Cohen, G.
Valle, J. W.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S565 - S566
[7] Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin ( plus GC) in patients (pts) with advanced biliary tract cancer (BTC)
Oh, D-Y.
He, A. R.
Qin, S.
Chen, L-T.
Okusaka, T.
Vogel, A.
Kim, J. W.
Lee, T.
Lee, M. A.
Kitano, M.
Burris, H. A.
Bouattour, M.
Tanasanvimon, S.
Zaucha, R. E.
Avallone, A.
Cundom, J. E.
Rokutanda, N.
Zotkiewicz, M.
Cohen, G.
Valle, J. W.
ANNALS OF ONCOLOGY, 2022, 33 : S1462 - S1463
[8] Outcomes by primary tumour location in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase III TOPAZ-1 study
He, A. R.
Valle, J. W.
Lee, C-K.
Ikeda, M.
Potemski, P.
Morizane, C.
Cundom, J. E.
Tougeron, D.
Dayyani, F.
Rokutanda, N.
Xiong, J.
Cohen, G.
Oh, D-Y.
ANNALS OF ONCOLOGY, 2022, 33 : S1467 - S1468
[9] Prognostic factors for progression-free and overall survival in advanced biliary tract cancer
Bridgewater, J.
Lopes, A.
Wasan, H.
Malka, D.
Jensen, L.
Okusaka, T.
Knox, J.
Wagner, D.
Cunningham, D.
Shannon, J.
Goldstein, D.
Moehler, M.
Bekaii-Saab, T.
McNamara, M. G.
Valle, J. W.
ANNALS OF ONCOLOGY, 2016, 27 (01) : 134 - 140
[10] Immunotherapy for Patients with advanced biliary tract Cancer (BTC) 3-years Update of TOPAZ-1 Study showed Doubling of the Overall Survival Rate with Durvalumab and Chemotherapy Combination
Sankawa, Yuri
ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 (06)

← 1 2 3 4 5 →